SCHEMBL26690138

SCHEMBL26690138

CCOC(=O)c1ncc2cnc(C)cn12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.41
GAA P10253 5/20 0.41
GLA P06280 3/20 0.41
ALDH1A1 P00352 8/20 0.40
HPGD P15428 6/20 0.40
HSD17B10 Q99714 4/20 0.39
RECQL P46063 1/20 0.39
MAPK1 P28482 2/20 0.38
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
NPC1 O15118 4/20 0.37
RAB9A P51151 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18376134 0.82 KDM4E (0.54) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL16517118 0.80 CYP1A2 (0.47) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL26116126 0.79 CDC7 (0.42) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL18366378 0.79 KDM4E (0.42) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL18366188 0.76 MAPT (0.46) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL4327194 0.76 MAPK1 (0.51) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL26690317 0.76 KDM4E (0.39) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL18366775 0.74 HDAC4 (0.39) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL23293888 0.73 KDM4E (0.44) KDM4EGAAALDH1A1HPGDNPC1
SCHEMBL26689995 0.73 ALDH1A1 (0.36) KDM4EGAAGLAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4526298-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS F. Hoffmann-La Roche AG (CH) 2025-03-26 EP disclosed
US-20250074913-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS HOFFMANN-LA ROCHE INC. (US) 2025-03-06 US disclosed
CN-119212989-A Pyrazole derivatives as STING agonists 豪夫迈·罗氏有限公司 2024-12-27 CN disclosed
WO-2023222644-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2023-11-23 WO disclosed
WO-2023222644-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2023-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250074913-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS STING1, CGAS, MAVS KDM4E 2535/4885GAA 3157/4885GLA 3263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.